Roxadustat combined with immunosuppressants for treatment of pure red cell aplasia with kidney injury
Annals of Hematology · 2024
DOI: 10.1007/s00277-024-06053-8 ↗Kurz gefasst
Fallbericht in der Zeitschrift Annals of Hematology, 2024. Verfasst von Lulu Fan und 3 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital of Chengdu Medical College, Chengdu, China. Hauptthemen laut MEDLINE: Red-Cell Aplasia, Pure, Immunosuppressive Agents, Glycine, Isoquinolines. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 6 Literaturangaben. Gefördert von: Sichuan medical research youth innovation project, Chengdu Jinniu District Medical Association kidney special topic key project.
Abstract (Originalsprache)
Pure red cell aplasia is a rare condition that may be congenital or associated with an underlying disease.Immunosuppressants are a commonly employed therapeutic option for the treatment of pure red cell aplasia;however, they are associated with considerable adverse effects, including nephrotoxicity. This case report describesa 74-year-old patient with pure red cell aplasia who developed long-term kidney injury following cyclosporinetherapy. Renal anemia is a common complication after chronic kidney injury and contributes to the poor outcome ofanemia treatment. Following a series of medication adjustments, the final treatment with roxarestat combined withsirolimus proved effective in delaying the impairment of this patient's kidney function, with the hemoglobin levelremaining above 100 g/L throughout. This case report demonstrates the efficacy of roxarestat in conjunction with animmunosuppressive agent in the treatment of pure red cell aplasia combined with kidney injury, with a dual effect ofalleviating the anemia and reducing serum creatinine levels.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First Affiliated Hospital of Chengdu Medical College, Chengdu, China.
- The First Affiliated Hospital of Chengdu Medical College, Chengdu, China. 158468931@qq.com.
Förderung
- Sichuan medical research youth innovation project
- Chengdu Jinniu District Medical Association kidney special topic key project
Zitieren
APA
Fan, L., Cao, L., Luo, Y., & Gao, F. (2024). Roxadustat combined with immunosuppressants for treatment of pure red cell aplasia with kidney injury. Annals of Hematology. https://doi.org/10.1007/s00277-024-06053-8
Vancouver
Fan L, Cao L, Luo Y, Gao F. Roxadustat combined with immunosuppressants for treatment of pure red cell aplasia with kidney injury. Annals of Hematology. 2024. doi:10.1007/s00277-024-06053-8
BibTeX
@article{Fan2024,
author = {Fan, Lulu and Cao, Lujia and Luo, Yangyan and Gao, Fang},
title = {Roxadustat combined with immunosuppressants for treatment of pure red cell aplasia with kidney injury},
journal = {Annals of Hematology},
year = {2024},
doi = {10.1007/s00277-024-06053-8}
}
EUVIMED